Assess anticipated impact of trial results (client and competition) on prescribing and identify which trial elements have the greatest impact on HCP perceptions across 9 countries
A longitudinal tracking study was designed and implemented across 9 global markets via rapid response surveys every few weeks over a period of six months. Surveys were sent to GPs, Endocrinologists and Cardiologists in EMEA, LATAM and APAC.
Identified the most significant trial elements by country and segment and determined the impact of competitor trial results on physicians’ perceptions and prescribing behaviors. Longitudinal design enabled ability to inform strategies in an agile manner for each country to optimize perceptions of client’s trial drug.